MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663–676 (2006).

2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131, 861–872 (2007).

3. Azuma, K. & Yamanaka, S. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies. Regen. Ter. 4, 36–47 (2016).

4. Huang, C.-Y. et al. Human iPSC banking: barriers and opportunities. J. Biomed. Sci. 26, 87 (2019).

5. Moradi, S. et al. Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations. Stem Cell Res. Ter. 10, 341 (2019).

6. Koyanagi-Aoi, M. et al. Diferentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc. Natl. Acad. Sci. 110, 20569–20574 (2013).

7. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T. & Yamanaka, S. Promotion of direct reprogramming by transformationdefcient Myc. Proc. Natl. Acad. Sci. 107, 14152–14157 (2010).

8. Baluapuri, A., Wolf, E. & Eilers, M. Target gene-independent functions of MYC oncoproteins. Nat. Rev. Mol. Cell Biol. 21, 255–267 (2020).

9. Varmus, H. E. Te molecular genetics of cellular oncogenes. Annu. Rev. Genet. 18, 553–612 (1984).

10. Oster, S. K., Mao, D. Y. L., Kennedy, J. & Penn, L. Z. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22, 1998–2010 (2003).

11. Beaulieu, M.-E., Castillo, F. & Soucek, L. Structural and biophysical insights into the function of the intrinsically disordered myc oncoprotein. Cells 9, 1038 (2020).

12. Amati, B. et al. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423–426 (1992).

13. Zhang, Q. et al. MB0 and MBI are independent and distinct transactivation domains in MYC that are essential for transformation. Genes 8, 134 (2017).

14. Kalkat, M. et al. MYC protein interactome profling reveals functionally distinct regions that cooperate to drive tumorigenesis. Mol. Cell 72, 836-848.e7 (2018).

15. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efcient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B 85, 348–362 (2009).

16. Tanabe, K., Nakamura, M., Narita, M., Takahashi, K. & Yamanaka, S. Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fbroblasts. Proc. Natl. Acad. Sci. 110, 12172–12179 (2013).

17. Okita, K. et al. A more efcient method to generate integration-free human iPS cells. Nat. Methods 8, 409–412 (2011).

18. Xing, Q. R. et al. Diversifcation of reprogramming trajectories revealed by parallel single-cell transcriptome and chromatin accessibility sequencing. Sci. Adv. 6, eaba1190 (2020)

19. Wolf, E. & Eilers, M. Targeting MYC proteins for tumor therapy. Annu. Rev. Cancer Biol. 4, 61–75 (2020).

20. Schwanhäusser, B. et al. Global quantifcation of mammalian gene expression control. Nature 473, 337–342 (2011).

21. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).

22. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl. Acids Res. 37, 1–13 (2009).

23. Wasylishen, A. R. et al. New model systems provide insights into Myc-induced transformation. Oncogene 30, 3727–3734 (2011).

24. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).

25. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).

26. Sone, M. et al. Hybrid cellular metabolism coordinated by Zic3 and Esrrb synergistically enhances induction of naive pluripotency. Cell Metab. 25, 1103-1117.e6 (2017).

27. Maekawa, M. et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474, 225–229 (2011).

28. Zahn-Zabal, M. et al. Te neXtProt knowledgebase in 2020: data, tools and usability improvements. Nucl. Acids Res. 48, D328–D334 (2020).

29. Rodriguez-Boulan, E. & Macara, I. G. Organization and execution of the epithelial polarity programme. Nat. Rev. Mol. Cell Biol. 15, 225–242 (2014).

30. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fbroblasts. Cell Stem Cell 7, 51–63 (2010).

31. Sakurai, K. et al. Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming. Cell Stem Cell 14, 523–534 (2014).

32. Pei, D., Shu, X., Gassama-Diagne, A. & Tiery, J. P. Mesenchymal–epithelial transition in development and reprogramming. Nat. Cell Biol. 21, 44–53 (2019).

33. Bonomi, S. et al. HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition. Nucl. Acids Res. 41, 8665–8679 (2013).

34. Price, D. H. Regulation of RNA polymerase II elongation by c-Myc. Cell 141, 399–400 (2010).

35. Welcker, M. et al. Te Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. 101, 9085–9090 (2004).

36. Tamkun, J. W. et al. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fbronectin and actin. Cell 46, 271–282 (1986).

37. Hynes, R. Integrins: A family of cell surface receptors. Cell 48, 549–554 (1987).

38. Närvä, E. et al. A strong contractile actin fence and large adhesions direct human pluripotent colony morphology and adhesion. Stem Cell Rep. 9, 67–76 (2017).

39. Santoro, R., Perrucci, G. L., Gowran, A. & Pompilio, G. Unchain My heart: integrins at the basis of iPSC cardiomyocyte diferentiation. Stem Cells Int. 2019, 1–20 (2019).

40. Hansson, J. et al. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep. 2, 1579–1592 (2012).

41. Ohta, S., Nishida, E., Yamanaka, S. & Yamamoto, T. Global splicing pattern reversion during somatic cell reprogramming. Cell Rep. 5, 357–366 (2013).

42. Nakagawa, M. et al. A novel efcient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2014).

43. Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).

44. Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951 (2019).

45. Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucl. Acids Res. 49, D545–D551 (2021).